Prolia

springboard

Pharma

Repatha helps Amgen overcome Prolia's LOE freefall in Q1

Sales of Amgen's Repatha were up 34% in Q1 to $876M and helped the company overcome the freefall of Prolia, which now faces biosimilar competition.

Kevin Dunleavy May 1, 2026 8:18am

Bradway

Amgen awards Bradway with $24.7M pay package in ’25

Apr 8, 2026 10:45am

Amgen

Amgen CEO critiques FDA push to reform biosimilars market

Nov 5, 2025 8:31am

The Top Line

A closer look at pharma’s top patent losses in 2025

Mar 21, 2025 9:00am

clock time delay cancelled month year hour

The top 10 drugs losing US exclusivity in 2025

Mar 17, 2025 3:00am

An artists 3D illustration of bones spongy structure seen close up

Amgen fends off Celltrion's proposed Prolia biosim until June

Jan 28, 2025 11:46am